Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > This drop has no reason

<< Previous

Bullboard Posts

Next >>

Comment by Unicorn9000on Jul 21, 2020 3:40pm

186 Views

Post# 31298130

RE:RE:This drop has no reason

ceccinapup wrote: i'm not in but still like to follow this
just remember to take profits every now and then when you can
better a little than nothing if it goes bad

great advice and I usually do it most of the time but instead I average up this time.

I think there is just too many good news we are waiting for before the end of July. Not to mention all these findings and reports of ifendropil being part of a Cure for Covid-19.

can't miss the run.. .It will run like SONA did.

scary good stuff

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China